Critical Path Institute Announces Expansion of Regulatory Science Consortium For Tuberculosis

Critical Path Institute is proud to announce that the Regulatory Science Consortium, an arm of the Critical Path to TB Drug Regimens (CPTR), has added ten new member organizations that include over 100 participants in five workgroups.